31-45 of 360
Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
MinuteCE®Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
Ticiana Leal, MD
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
MinuteCE®On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
Ticiana Leal, MD
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
MinuteCE®The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
The Evidence Base: Key Trials and Emerging Data
MinuteCE®The Evidence Base: Key Trials and Emerging Data
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
MinuteCE®Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- advertisement
From Data to Decision: Patient Selection and Real-World Application
MinuteCE®From Data to Decision: Patient Selection and Real-World Application
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
MinuteCE®From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
MinuteCE®Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
The Power of Timing: Therapies That Change Outcomes
MinuteCE®The Power of Timing: Therapies That Change Outcomes
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
MinuteCE®ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Precision in Practice—Bringing Targeted Therapy to mHSPC
MinuteCE®Precision in Practice—Bringing Targeted Therapy to mHSPC
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- advertisement
Novel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations
CME/CENovel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations
Alexandria May, PharmD, BCPS
Helena A. Yu, MD
Vicki Sherry, DNP, ANP-BC, AOCNP
Tiffany Traina, MD
Javier Cortes, MD, PhD
Current Unmet Needs in First-Line Treatment of Metastatic TNBC
MinuteCE®Current Unmet Needs in First-Line Treatment of Metastatic TNBC
Javier Cortes, MD, PhD
